143 related articles for article (PubMed ID: 1069547)
1. Immunotherapy of cancer patients with Bacillus Calmette-Guérin: summary of four years of experience in Japan.
Torisu M; Fukawa M; Nishimura M; Harasaki H; Kai S; Tanaka J
Ann N Y Acad Sci; 1976; 277(00):160-86. PubMed ID: 1069547
[TBL] [Abstract][Full Text] [Related]
2. Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder.
Jurincic-Winkler C; Metz KA; Beuth J; Sippel J; Klippel KF
Anticancer Res; 1995; 15(6B):2771-6. PubMed ID: 8669862
[TBL] [Abstract][Full Text] [Related]
3. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY; Inci K; Erkan I; Ozen H
J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
[TBL] [Abstract][Full Text] [Related]
4. Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer.
Niwa N; Kikuchi E; Matsumoto K; Kosaka T; Mizuno R; Oya M
J Urol; 2018 Jun; 199(6):1446-1451. PubMed ID: 29307686
[TBL] [Abstract][Full Text] [Related]
5. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
6. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
Winters WD; Lamm DL
Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
Gandhi NM; Morales A; Lamm DL
BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
[TBL] [Abstract][Full Text] [Related]
9. Complications of BCG immunotherapy in patients with cancer.
Sparks FC; Silverstein MJ; Hunt JS; Haskell CM; Pilch YH; Morton DL
N Engl J Med; 1973 Oct; 289(16):827-30. PubMed ID: 4763426
[No Abstract] [Full Text] [Related]
10. Immunotherapy in viral warts with intradermal
Podder I; Bhattacharya S; Mishra V; Sarkar TK; Chandra S; Sil A; Pal S; Kumar D; Saha A; Shome K; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):411. PubMed ID: 27852999
[TBL] [Abstract][Full Text] [Related]
11. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
12. Effect of repeated intradermal injections of heat-inactivated Mycobacterium bovis bacillus Calmette-Guérin in adult asthma.
Shirtcliffe PM; Easthope SE; Weatherall M; Beasley R
Clin Exp Allergy; 2004 Feb; 34(2):207-12. PubMed ID: 14987299
[TBL] [Abstract][Full Text] [Related]
13. Bacillus Calmette-Guérin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract.
Nonomura N; Ono Y; Nozawa M; Fukui T; Harada Y; Nishimura K; Takaha N; Takahara S; Okuyama A
Eur Urol; 2000 Dec; 38(6):701-4;discussion 705. PubMed ID: 11111187
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of cancer patients with BCG: summary of ten years experience in Japan.
Torisu M; Iwasaki K; Sakata M
Dev Biol Stand; 1986; 58 ( Pt A)():451-6. PubMed ID: 3596049
[TBL] [Abstract][Full Text] [Related]
15. The immunotherapy of acute myelogenous leukaemia using intravenous BCG.
Whittaker JA; Slater AJ
Br J Haematol; 1977 Feb; 35(2):263-73. PubMed ID: 322696
[TBL] [Abstract][Full Text] [Related]
16. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
[TBL] [Abstract][Full Text] [Related]
17. BCG immunotherapy of lung cancer.
Holmes EC
Jpn J Surg; 1980 Mar; 10(1):1-6. PubMed ID: 7373947
[TBL] [Abstract][Full Text] [Related]
18. Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non-muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013.
Martínez-Piñeiro L; Portillo JA; Fernández JM; Zabala JA; Cadierno I; Moyano JL; Solsona E; Unda M; Beardo P; Rodríguez-Molina J; Chantada V; Palou J; Muntañola P; Alonso Dorrego JM; Pérez-Garcia FJ; Silva JM; Chesa N; Montesinos M; Ojea A; Madero R; Martínez-Piñeiro JA
Eur Urol; 2015 Aug; 68(2):256-62. PubMed ID: 25794457
[TBL] [Abstract][Full Text] [Related]
19. [Granulomatous pneumonia as a complication of intravesical BCG immunotherapy--a case report].
Rogoziński P; Taracha-Guz D; Pęcikiewicz P; Kachel T; Dubiel G; Wandzel P; Bruliński K
Pneumonol Alergol Pol; 2014; 82(2):163-9. PubMed ID: 24615200
[TBL] [Abstract][Full Text] [Related]
20. Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
Steinberg RL; Nepple KG; Velaer KN; Thomas LJ; O'Donnell MA
Urol Oncol; 2017 Dec; 35(12):670.e7-670.e14. PubMed ID: 28801026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
